Rubric Capital Management (New York)’s Antares Pharma, Inc. ATRS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
|
|||||
|
2022
Q1 | $44.7M | Buy |
|
|||||
|
2021
Q4 | $38.6M | Buy |
|
|||||
|
2021
Q3 | $36.4M | Buy |
|
|||||
|
2021
Q2 | $41.4M | Buy |
|
|||||
|
2021
Q1 | $35.9M | Buy |
|
|||||
|
2020
Q4 | $14.2M | Buy |
|
|||||
|
2019
Q1 | – | Sell |
|
|||||
|
2018
Q4 | $35K | Buy |
|
|||||
|
2017
Q4 | – | Sell |
|
|||||
|
2017
Q3 | $1.05M | Sell |
|
|||||
|
2017
Q2 | $10.3M | Buy |
|
|||||
|
2017
Q1 | $6.74M | Buy |
|
|||||
|
2016
Q4 | $2.71M | Buy |
|